Health

Canadian company cleared to test flu vaccine in the United States

NEWS IN BRIEF — Posted Jan. 31, 2005

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Food and Drug Administration has given the go ahead to the Vancouver-based vaccine manufacturer ID Biomedical Corp. to begin testing its influenza vaccine under an investigational new drug application, according to a statement issued by the company this month.

ID Biomedical intends to enter the U.S. market by 2007, although it may do so earlier dependent on regulatory approval. This clearance is part of that process.

"We are very excited to initiate clinical testing of Fluviral in the United States," said Louis F. Fries, MD, vice president of clinical affairs at ID Biomedical. "We believe this trial data ... will be necessary to support licensure of Fluviral for the U.S. market."

ID Biomedical currently has the capacity to manufacture 22 million doses, with much of that being purchased by the Canadian government. The company intends to expand its capacity to 50 million by 2007.

The company is also developing an intranasal version of the vaccine. According to data, also released in January, use by healthy adults ages 18 to 64 was effective at preventing the flu without significant adverse events.

Note: This item originally appeared at http://www.ama-assn.org/amednews/2005/01/31/hlbf0131.htm.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn